Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

False or pirated antimalarial drugs freely obtainable in Cameroon

01.07.2004


Medical drug falsification mainly concerns those which are in high demand, such as antimalarials in African regions where malaria is endemic. IRD researchers (1) have examined the quality of antimalarial medicines available from informal distribution networks in Cameroon. They also assessed the impact of malaria patients’ taking these medicines, obtained on the illicit market, on their health. Self-medication is common but when it relies on supplies of poor-quality drugs it is ineffectual for controlling the disease. Quite the reverse, as it favours proliferation of treatment-resistant parasites leading to treatment failures and to people spending money futilely on health. Government measures for controlling such fraud are clearly necessary if public health is to be protected.

Large-scale diffusion and sale of medicines that do not comply with regulations or are poor in quality, especially in African countries, stems from several factors. These include: the intensification of trade, a growing demand for medical treatments or vaccines, a proliferation of small pharmaceutical industries, and inadequate regulation of manufacture and commerce of such products. Counterfeiting, which affects all classes of medical drugs, concerns mainly antibiotics and anti-parasitic drugs. This is the case of antimalarials, under high demand in African countries where malaria is endemic. This demand sustains the informal trade of false or poor quality antimalarial drugs, which is the final stage for distribution networks of counterfeit medicines that escape any control by health authorities.

To assess the effect this illegal sector has on malaria control, an IRD team investigated the origin and quality of several antimalarial drugs in tablet or capsule form. They were purported to contain chloroquine, quinine or a sulfadoxin-pyrimethamin mixture. These medicines were collected between 2001 and 2002 on the markets, from street vendors or patients who had obtained supplies from outside official networks, in several towns and villages in Cameroon.



A total of 284 samples obtained from 132 different points of sale in 16 localities were submitted to colorimetric tests and chromatographic analyses. The team succeeded in determining if the active principle contained in these medicines really corresponded to that for which they were being sold and approximately evaluate its quantity. They showed that 38% of the drugs supposedly containing chloroquine, 74% said to contain quinine and 12% of those purported to have sulfadoxin-pyrimethamin in fact contained either no active principle, one insufficient in quantity, or an active principle of another sort, or even some unknown compounds. Out of all the samples studied, only 118 bore mention of their origin, 61 coming from the European Union, 6 from East Europe, 39 from Asia and 12 from Africa. In most cases it was impossible to determine the names of pharmaceutical companies responsible either for marketing or for their manufacture. Other analyses were conducted on 15 samples sold purportedly containing chloroquine and quinine, samples collected from 15 patients who had acquired them on the informal market, without prior consultation. Only six of these samples proved to be of acceptable quality. Eight among the 15 patients gave negative urine tests for the active principle. Such absence of any trace of the latter results from self-medication with false drugs or under-dosed medicines with insufficient antimalarial active principle.

The illegal trade and free use of these non-compliant products can aggravate the clinical state of patients, possibly leading to death from the disease itself owing to the ineffectiveness of these treatments. These practices often induce a prolongation of treatment times which affects health expenditure. Moreover, they favour the selection of pathogens resistant to authentic antimalarial drugs, effectively holding back the actions of research and national malaria control programmes.

However, the practice of self-medication, on condition that it is based on medicines that comply with quality and dosage requirements, could represent a strategy for rapid, early intervention in case of malaria attack. Applied early, it could reduce the risk of patients’ deterioration towards the more severe forms of the disease. In Cameroon, as in most African countries, self-medication is common. People suffering from the disease avoid medical consultations because of their cost, often prohibitive for low-income households, and the absence of or distance from health care facilities. Obtaining such drugs on the informal market is cheaper than buying them from dispensaries authorized to issue medicines.

Government measures therefore appear necessary to provide better regulation of import and distribution of good quality generic medicines, fraud control and training (health authority personnel, pharmacists, medicines, etc.), in order to improve access to treatments, medical follow-up of patients and to contribute effectively to malaria control.

Bénédicte Robert | EurekAlert!
Further information:
http://www.ird.fr

More articles from Health and Medicine:

nachricht Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München

nachricht Second cause of hidden hearing loss identified
20.02.2017 | Michigan Medicine - University of Michigan

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Microhotplates for a smart gas sensor

22.02.2017 | Power and Electrical Engineering

Scientists unlock ability to generate new sensory hair cells

22.02.2017 | Life Sciences

Prediction: More gas-giants will be found orbiting Sun-like stars

22.02.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>